Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation

被引：33

作者：

Carey R.M. ^{[1
]}

Wang Z.-Q. ^{[1
]}

Siragy H.M. ^{[1
]}

机构：

[1] Department of Medicine, University of Virginia, School of Medicine, Charlottesville

来源：

Current Hypertension Reports | 2000年 / 2卷 / 2期

关键词：

Nitric Oxide; Bradykinin; Valsartan; Candesartan; Receptor Blockade;

D O I：

10.1007/s11906-000-0082-3

中图分类号：

学科分类号：

摘要：

In the past, virtually all of the physiologic actions of angiotensin II (ANG II) were thought to be mediated by the type-1 ANG II receptor. However, there is now a compelling body of evidence suggesting that the type-2 (AT 2) receptor is an important regulator of renal function and blood pressure (BP). The AT2 receptor stimulates a bradykinin (BK)-nitric oxide (NO)-cyclic GMP vasodilator cascade in blood vessels and in the kidney. Recent studies have shown that absence of the AT2 receptor lends to pressor and natriuretic hypersensitivity to ANG II. Furthermore, there is now excellent evidence that the AT2 receptor mediates pressure natriuresis. The AT2 receptor also stimulates the conversion of prostaglandin E2 (PGE2) to PGF2. In addition, it is now apparent that the therapeutic reduction in BP with AT1 receptor blockade (eg, losartan, valsartan, candesartan) is mediated by ANG II stimulation of the AT2 receptor, leading to increased levels of BK, NO, and cGMP. Current evidence predicts that AT2 receptor agonists would be beneficial in the treatment of hypertension. Copyright © 2000 by Current Science Inc.

引用

页码：198 / 201

页数：3

共 29 条

[1]

Matsukawa T., Ichikawa I., Biological functions of angiotensin and its receptors, Am Rev Physiol, 59, pp. 395-412, (1997)

[2]

Ardaillou R., Angiotensin II receptors, J Am Soc Nephrol, 10, (1999)

[3]

Horiuchi M., Akishita M., Dzau V.J., Recent progress in angiotensin II type 2 receptor research in the cardiovascular system, Hypertension, 33, pp. 613-621, (1999)

[4]

Ozono R., Wang Z.-Q., Moore A.G., Et al., Expression of the subtype-2 angiotensin II (AT2) receptor protein in rat kidney, Hypertension, 30, pp. 1238-1246, (1997)

[5]

Wang Z.-Q., Moore A.F., Ozono R., Et al., Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart, Hypertension, 32, pp. 78-83, (1998)

[6]

Park M.N., Li X.F., Cowley Jr. A.W., Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney, Am J Physiol, 277, (1999)

[7]

Nora E.H., Munzenmaier D.H., Hansen-Smith F.M., Et al., Localization of the ANG II type-2 receptor in the micro-circulation of skeletal muscle, Am J Physiol, 275, (1998)

[8]

Siragy H.M., Carey R.M., The subtype 2(AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats, J Clin Invest, 100, pp. 264-269, (1997)

[9]

Gohlke P., Pees C., Unger T., AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by kinin-dependent mechanisms, Hypertension, 31, pp. 349-355, (1998)

[10]

Siragy H.M., Carey R.M., Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model, Hypertension, 33, pp. 1237-1242, (1999)

← 1 2 3 →